Assure Holdings Corp. (NASDAQ:IONM – Get Rating) saw a significant decline in short interest in the month of April. As of April 30th, there was short interest totalling 2,900 shares, a decline of 54.0% from the April 15th total of 6,300 shares. Currently, 0.0% of the company’s shares are sold short. Based on an average daily trading volume, of 7,500 shares, the days-to-cover ratio is presently 0.4 days.
Several research analysts have commented on IONM shares. Benchmark started coverage on shares of Assure in a research note on Tuesday, April 5th. They set a “buy” rating and a $9.00 price objective for the company. Zacks Investment Research raised shares of Assure from a “sell” rating to a “hold” rating in a research note on Thursday, January 20th.
An institutional investor recently bought a new position in Assure stock. Manatuck Hill Partners LLC acquired a new position in Assure Holdings Corp. (NASDAQ:IONM – Get Rating) in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 62,500 shares of the company’s stock, valued at approximately $377,000. Manatuck Hill Partners LLC owned 0.53% of Assure at the end of the most recent reporting period. 1.26% of the stock is owned by institutional investors and hedge funds.
Assure (NASDAQ:IONM – Get Rating) last issued its earnings results on Monday, March 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.01). The company had revenue of $9.66 million for the quarter, compared to analysts’ expectations of $8.90 million. Assure had a negative net margin of 9.44% and a negative return on equity of 11.57%. During the same period in the prior year, the firm posted ($0.05) earnings per share. On average, analysts predict that Assure will post -0.06 earnings per share for the current year.
Assure Company Profile (Get Rating)
Assure Holdings Corp., through its subsidiaries, provides technical and professional intraoperative neuromonitoring surgical support services primarily associated with spine and head surgeries. It delivers various clinical and operational services, including scheduling of the interoperative neurophysiologist and supervising practitioner, real time monitoring, patient advocacy, and billing services to support surgeons and medical facilities during invasive procedures.
- Get a free copy of the StockNews.com research report on Assure (IONM)
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
- Carvana Insiders Buy Shares But Maybe You Shouldn’t
- Dutch Bros Gets Scalded By Inflation
Receive News & Ratings for Assure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assure and related companies with MarketBeat.com's FREE daily email newsletter.